Clinical trial
A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
NCT02385019 is registered in ClinicalTrials.gov with Instituto de Medicina Molecular João Lobo Antunes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
- Lead sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- March 31, 2015
- Completion date
- December 31, 2019
- Enrollment
- 22 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.